[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
[3]Shenzhen Geno-Immune Medical Institute;
Shenzhen 518057;
China;
[4]Innovative Cellular Therapeutics Co.;
Ltd.;
Shanghai 201499;
China;
[1]Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;
Peking University Institute of Hematology;
Peking University People’s Hospital;
Beijing 100044;
China;
[2]Collaborative Innovation Center of Hematology;
Peking University;
Beijing 100084;
China;
Donor-derived CD19-targeted T cell infusion; Hematopoietic stem cell transplantation; B cell acute lymphoblastic leukemia; Minimal residual disease;